Cancer testing readiness on Day One of drug launch – Lessons learnt

Companion diagnostics (CDx) development is entrusted to a CDx partner. However, commercialization of a CDx is becoming increasingly important. Many pharma companies have questions regarding CDx commercialization as they need to ensure that all indicated patients will be tested as early as possible. This webinar addresses the key questions of how to prepare for successful CDx commercialization and what the collaboration with a pharma partner needs to cover. The speakers will discuss this from three different perspectives: US commercial lab; UK academic lab; and diagnostic provider. The expertise shared in this webinar is especially valuable for pharma companies that are going to launch their drug in combination with a CDx.

Key learning objectives

• Learn how to get CDx testing set up in time for drug availability.
• Understand how to avoid the potential pitfalls of CDx testing readiness at a country and regional level.
• Learn from examples and lessons garnered from several years of CDx launches.

Who should attend?

Commercial leaders of pharma companies

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.